WS03.1 Optimization and testing of SPLUNC1-derived peptides with potent in vitro and in vivo ENaC inhibitory activity for the treatment of cystic fibrosisD.J. Christensen, S. Terryah, J. Neill, J. Hairr,R. Fellner, T.M. Crowder,Robert TarranJournal of Cystic Fibrosis（2016）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
